Signpost patients to The GLP-1 Legacy Read a Sample Chapter The next phase after GLP-1 weight loss The first GLP-1 story was weight loss
Written informed consent was waived by the IRB due to the retrospective nature of the study
Injections: A Practical Comparison For patients weighing both options, some real-world differences matter beyond the clinical trial results
doi: 10.1016/S0022-3999(01)00315-4 Summary Keywords Sensewear armband, myalgic encephalomyelitis/chronic fatigue syndrome, vitamin B12 nasal drops, vitamin B12 serum concentration, RAND 36 questionnaire Citation van Campen CLMC, Riepma K and Visser FC (2019) Open Trial of Vitamin B12 Nasal Drops in Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Comparison of Responders and Non-Responders
Research shows the delay is most pronounced during the first 1 to 2 hours after a meal, which is why many people notice their worst reflux symptoms shortly after eating rather than on an empty stomach
For type 2 diabetes, NICE recommends GLP-1 receptor agonists when triple oral therapy is ineffective and BMI is 35 kg/m or higher (with lower thresholds for certain ethnic groups)